Does Medicare Cover Prostate Cancer Treatment — Complete Guide 202
Does Medicare cover prostate cancer treatment in 2026? Prostate cancer is the most common cancer among Medicare-eligible men — with approximately 268,000 new cases diagnosed annually in the United States and the majority occurring in men over 65. The good news is that yes — does Medicare cover prostate cancer treatment in 2026 — and the coverage is comprehensive across all major prostate cancer treatment modalities including surgery, radiation, hormone therapy, chemotherapy, and immunotherapy. In this complete guide we explain exactly what Medicare covers for prostate cancer treatment in 2026. All information is sourced from Medicare.gov and CMS.gov.
Also Read —
- Does Medicare Cover Cancer Treatment 2026
- Does Medicare Cover Radiation Therapy 2026
- Medicare Deductible 2026 — Complete Breakdown
What You Will Learn — Does Medicare Cover Prostate Cancer
- Does Medicare cover prostate cancer treatment in 2026
- Does Medicare cover PSA testing for prostate cancer screening
- Does Medicare cover prostate biopsy
- Does Medicare cover prostatectomy surgery
- Does Medicare cover radiation therapy for prostate cancer
- Does Medicare cover hormone therapy for prostate cancer
- Does Medicare cover chemotherapy for prostate cancer
- Does Medicare cover immunotherapy for prostate cancer
- How much does prostate cancer treatment cost with Medicare
- Does Medicare Advantage cover prostate cancer
- Frequently asked questions about Medicare prostate cancer coverage 2026
Does Medicare Cover Prostate Cancer Treatment in 2026?
Yes — does Medicare cover prostate cancer treatment in 2026 — comprehensively across all stages and treatment modalities. Medicare Part B covers prostate cancer screening including the annual PSA test at $0 for qualifying men, diagnostic testing including prostate biopsy, surgical treatment, and radiation therapy. Medicare Part D covers oral hormone therapy and other oral cancer medications. Medicare Part B covers physician-administered treatments including injectable hormone therapy, IV chemotherapy, and immunotherapy infusions.
Prostate cancer treatment has evolved significantly with multiple effective treatment options available — including active surveillance for low-risk disease, surgery, radiation, hormone therapy, and emerging targeted therapies. Understanding does Medicare cover prostate cancer across all these treatment approaches ensures Medicare beneficiaries can access the most appropriate treatment for their specific cancer without financial barriers.
Does Medicare Cover PSA Testing for Prostate Cancer?
Does Medicare cover PSA testing for prostate cancer screening in 2026? Yes — Medicare Part B covers annual PSA (prostate-specific antigen) blood testing for prostate cancer screening at $0 — no deductible and no coinsurance — for all Medicare-enrolled men aged 50 and older.
Annual PSA Screening at $0
Medicare covers one PSA blood test per year at $0 for all male Medicare beneficiaries aged 50 and older. This free annual screening benefit is one of the most important cancer prevention benefits in Medicare — allowing early detection of prostate cancer when treatment is most effective.
Digital Rectal Examination — Also Covered
Medicare covers an annual digital rectal examination (DRE) as part of the prostate cancer screening benefit at $0 for men aged 50 and older. The DRE and PSA test together constitute the standard annual prostate cancer screening covered at no cost.
PSA for Monitoring — Covered at $0
For men already diagnosed with prostate cancer or who have undergone treatment PSA tests ordered to monitor disease status are covered as diagnostic laboratory tests at $0 — regardless of frequency. PSA monitoring is essential for detecting prostate cancer recurrence and Medicare’s $0 coverage makes ongoing monitoring completely affordable for prostate cancer survivors.
Does Medicare Cover Prostate Biopsy?
Does Medicare cover prostate biopsy in 2026? Yes — Medicare Part B covers prostate biopsy at 80% after the $257 annual Part B deductible when medically ordered to evaluate elevated PSA or other prostate cancer indicators.
Transrectal Ultrasound-Guided Prostate Biopsy (TRUS)
Traditional transrectal ultrasound-guided prostate biopsy — the most common prostate biopsy technique — is covered by Medicare at 80% after the deductible. Coverage includes:
- The biopsy procedure itself
- Ultrasound guidance
- Pathological examination of biopsy cores
MRI-Guided Prostate Biopsy
MRI-guided prostate biopsy — increasingly used for more accurate targeting of suspicious lesions — is covered by Medicare including:
- Prostate MRI for biopsy targeting — covered at 80% after deductible
- Fusion biopsy combining MRI and ultrasound guidance — covered
Prostate Biopsy Costs with Medicare
With Original Medicare — approximately $120 to $250 your 20% after the $257 annual deductible With Medigap Plan G — $0 after the annual deductible
Does Medicare Cover Prostatectomy Surgery?
Does Medicare cover prostatectomy surgery for prostate cancer in 2026? Yes — Medicare covers radical prostatectomy — surgical removal of the prostate gland — as a medically necessary cancer treatment.
Types of Prostatectomy Medicare Covers
Open radical prostatectomy — traditional open surgical approach — covered under Medicare Part A for inpatient procedures.
Laparoscopic radical prostatectomy — minimally invasive approach using small incisions — covered under Part B for outpatient or Part A for inpatient.
Robotic-assisted radical prostatectomy (RALP) — the most commonly performed approach using the da Vinci robotic system — covered by Medicare. Medicare does not pay extra for robotic assistance — it pays the standard surgical rate and the hospital includes the robotic cost in its facility charge.
Prostatectomy Costs with Medicare
Inpatient prostatectomy:
- Part A deductible — $1,676 per benefit period
- Days 1 to 60 — $0 after deductible
- Surgeon fee — 20% Part B coinsurance
With Medigap Plan G — prostatectomy costs $0 after the $257 annual Part B deductible — covering both the Part A deductible and all Part B coinsurance.
Does Medicare Cover Radiation Therapy for Prostate Cancer?
Does Medicare cover radiation therapy for prostate cancer in 2026? Yes — Medicare Part B covers all major forms of radiation therapy for prostate cancer at 80% after the $257 annual Part B deductible.
External Beam Radiation Therapy (EBRT) — Covered
Conventional external beam radiation — covered Intensity-modulated radiation therapy (IMRT) — covered Stereotactic body radiation therapy (SBRT) — including CyberKnife and Gamma Knife approaches — covered Proton beam therapy — covered for prostate cancer when medically justified
Brachytherapy — Covered
Brachytherapy — radioactive seed implantation into the prostate — covered by Medicare as an outpatient procedure at 80% after the deductible.
Radiation Therapy Costs with Medicare
A full course of IMRT — approximately 40 to 45 treatments — can have Medicare-approved amounts of $25,000 to $60,000. Your 20% coinsurance without a supplement — approximately $5,000 to $12,000 total for the treatment course.
With Medigap Plan G — all radiation therapy costs $0 after the $257 annual deductible. This is one of the most financially significant Plan G benefits for prostate cancer patients — potentially saving $5,000 to $12,000 for a full radiation course.
Does Medicare Cover Hormone Therapy for Prostate Cancer?
Does Medicare cover hormone therapy (ADT — androgen deprivation therapy) for prostate cancer in 2026? Yes — and the coverage pathway depends on how the hormone therapy is administered.
Injectable/Implantable Hormone Therapy — Part B
Physician-administered hormone therapy injections and implants are covered under Medicare Part B at 80% after the deductible:
- Leuprolide (Lupron, Eligard) — LHRH agonist injections — covered Part B
- Goserelin (Zoladex) — implant administered in office — covered Part B
- Histrelin (Vantas) — annual implant — covered Part B
- Degarelix (Firmagon) — GnRH antagonist injection — covered Part B
Oral Hormone Therapy — Part D
Oral androgen receptor inhibitors are covered under Medicare Part D:
- Enzalutamide (Xtandi) — covered Part D — expensive — $2,000 annual cap critical
- Apalutamide (Erleada) — covered Part D
- Darolutamide (Nubeqa) — covered Part D
- Bicalutamide — generic available — Tier 1 or 2 — very affordable
- Flutamide — generic available — covered Part D
Abiraterone (Zytiga, Yonsa) — covered Part D — for castration-resistant prostate cancer — generic available significantly reducing cost.
The $2,000 annual Part D out-of-pocket maximum is critically important for prostate cancer patients taking expensive oral hormone therapy — enzalutamide retail cost exceeds $180,000 per year without insurance.
Does Medicare Cover Chemotherapy for Prostate Cancer?
Does Medicare cover chemotherapy for prostate cancer in 2026? Yes — Medicare covers chemotherapy for advanced and castration-resistant prostate cancer.
IV Chemotherapy — Part B
Intravenous chemotherapy administered in physician offices or outpatient infusion centers is covered under Medicare Part B at 80% after the deductible:
- Docetaxel — first-line chemotherapy for metastatic castration-resistant prostate cancer — covered Part B
- Cabazitaxel (Jevtana) — second-line chemotherapy — covered Part B
With Medigap Plan G — IV chemotherapy costs $0 after the annual deductible. This is one of the most important financial benefits for advanced prostate cancer patients — IV chemotherapy can cost tens of thousands of dollars per treatment cycle.
Does Medicare Cover Immunotherapy for Prostate Cancer?
Does Medicare cover immunotherapy for prostate cancer in 2026? Yes — Medicare covers prostate cancer immunotherapy.
Sipuleucel-T (Provenge) — Part B
Sipuleucel-T — the only FDA-approved therapeutic cancer vaccine — is an immunotherapy for metastatic castration-resistant prostate cancer. Provenge is manufactured from the patient’s own immune cells and administered as three infusions. Medicare Part B covers Provenge infusions at 80% after the deductible — given the extremely high cost of this treatment Medigap Plan G provides significant financial protection.
PARP Inhibitors — Part D
PARP inhibitors for BRCA-mutated prostate cancer:
- Olaparib (Lynparza) — covered Part D — $2,000 annual cap applies
- Rucaparib (Rubraca) — covered Part D
- Niraparib (Zejula) — covered Part D
Lutetium PSMA Therapy — Part B
Lutetium-177 PSMA-617 (Pluvicto) — radioligand therapy for metastatic castration-resistant prostate cancer — is administered in specialized nuclear medicine settings and covered under Medicare Part B at 80% after the deductible.
How Much Does Prostate Cancer Treatment Cost with Medicare in 2026?
PSA Screening and Monitoring
Annual PSA screening — $0 Monitoring PSA after treatment — $0 as diagnostic lab
Prostate Biopsy
With Original Medicare — approximately $120 to $250 your 20% With Medigap Plan G — $0 after annual deductible
Prostatectomy Surgery
With Original Medicare — approximately $1,700 to $2,500 (Part A deductible plus surgeon coinsurance) With Medigap Plan G — $0 after annual deductible
Radiation Therapy
With Original Medicare — approximately $5,000 to $12,000 for full IMRT course With Medigap Plan G — $0 after annual deductible
Oral Hormone Therapy Under Part D
Bicalutamide generic — approximately $10 to $30 per month Enzalutamide Xtandi — $2,000 annual Part D maximum — critical protection
Injectable Hormone Therapy Under Part B
Lupron quarterly injection — Medicare-approved approximately $1,500 to $2,500 Your 20% — approximately $300 to $500 per injection With Medigap Plan G — $0 after annual deductible
Does Medicare Advantage Cover Prostate Cancer?
Does Medicare Advantage cover prostate cancer treatment in 2026? Yes — all Medicare Advantage plans must cover prostate cancer treatment as Medicare-required services.
Prior authorization — most Medicare Advantage plans require prior authorization for surgery, radiation, and expensive medications. Your oncologist and urologist handle authorization but delays can sometimes occur.
In-network oncology and urology — verify your cancer specialists and treatment centers are in-network before beginning treatment.
Annual out-of-pocket maximum — prostate cancer treatment costs count toward the $9,350 annual maximum — most prostate cancer patients reach this maximum during active treatment.
Part D drug coverage — expensive oral hormone therapies are subject to the $2,000 annual Part D maximum — the same protection applies under Medicare Advantage drug coverage.
Frequently Asked Questions — Does Medicare Cover Prostate Cancer
Does Medicare cover prostate cancer treatment in 2026?
Yes — does Medicare cover prostate cancer comprehensively in 2026 including free annual PSA screening at $0, prostate biopsy at 80%, prostatectomy surgery, radiation therapy, hormone therapy through Part B and Part D, chemotherapy, immunotherapy including Provenge, and PARP inhibitors under Part D. With Medigap Plan G most prostate cancer treatment costs $0 after the $257 annual deductible.
Does Medicare cover the PSA test for free?
Yes — Medicare covers one annual PSA blood test at $0 for all male Medicare beneficiaries aged 50 and older. PSA monitoring after prostate cancer diagnosis or treatment is also covered at $0 as diagnostic laboratory testing.
Does Medicare cover robotic prostate surgery?
Yes — Medicare covers robotic-assisted radical prostatectomy (RALP) using the da Vinci system. Medicare pays the standard surgical rate for prostatectomy — the hospital includes the robotic facility cost in its charge. With Medigap Plan G robotic prostatectomy costs $0 after the annual deductible.
How much does radiation therapy for prostate cancer cost with Medicare?
A full course of IMRT radiation for prostate cancer — 40 to 45 treatments — costs approximately $5,000 to $12,000 in 20% coinsurance with Original Medicare alone. With Medigap Plan G radiation therapy costs $0 after the $257 annual deductible — potentially saving thousands of dollars.
Does Medicare cover Lupron hormone therapy for prostate cancer?
Yes — Medicare Part B covers Lupron (leuprolide) injections for prostate cancer hormone therapy at 80% after the $257 annual deductible. Each quarterly injection costs approximately $300 to $500 in coinsurance without a supplement. With Medigap Plan G Lupron injections cost $0 after the annual deductible.
Summary — Does Medicare Cover Prostate Cancer 2026
Does Medicare cover prostate cancer treatment in 2026? Yes — Medicare provides comprehensive coverage for all stages and treatment modalities of prostate cancer including free PSA screening, biopsy, surgery, radiation therapy, hormone therapy, chemotherapy, and immunotherapy. The $2,000 annual Part D maximum protects patients taking expensive oral hormone therapies.
For prostate cancer patients Medigap Plan G provides extraordinary financial protection — covering the 20% coinsurance on radiation therapy potentially saving $5,000 to $12,000 for a full treatment course, eliminating injection coinsurance for hormone therapy, and making surgery effectively free after the annual deductible. Prostate cancer patients are among the Medicare beneficiaries who benefit most dramatically from Medigap Plan G coverage.
For free help understanding your Medicare prostate cancer coverage contact your State Health Insurance Assistance Program (SHIP) at shiphelp.org or call Medicare free at 1-800-633-4227.
This guide is for informational purposes only. Always consult your urologist and oncologist and verify current Medicare coverage at Medicare.gov.
Sources: Medicare.gov | CMS.gov | SSA.gov | AARP.org
Last updated: April 2026 | Author: James Carter, Independent Medicare Research Analyst
